Constrained β-alanine based GpIIb/IIIa antagonists
- 8 July 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (13) , 1773-1778
- https://doi.org/10.1016/s0960-894x(97)00311-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Non-Peptide Fibrinogen Receptor Antagonists. 7. Design and Synthesis of a Potent, Orally Active Fibrinogen Receptor AntagonistJournal of Medicinal Chemistry, 1995
- Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp Sequence of Fibrinogen. (Aminobenzamidino)succinyl (ABAS) Series of Orally Active Fibrinogen Receptor AntagonistsJournal of Medicinal Chemistry, 1995
- SC-54684A: An Orally Active Inhibitor of Platelet AggregationCirculation, 1995
- Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy menClinical Pharmacology & Therapeutics, 1994
- Interruption of Thrombosis and Hemostasis by Anti-Platelet AgentsToxicologic Pathology, 1993
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Platelets and Thrombolytic TherapyNew England Journal of Medicine, 1990
- The platelet membrane glycoprotein IIb-IIIa complexBlood, 1988
- Platelet Membrane Glycoprotein IIb/IIIa: Member of a Family of Arg-Gly-Asp—Specific Adhesion ReceptorsScience, 1986